APS Testing Beyond the Criteria: The Value of Criteria and Non-Criteria aPL
Understanding the contribution of broader aPL testing to APS diagnosis and clinical evaluation.
- Antiphospholipid syndrome (APS) is a systemic autoimmune disorder associated with significant thrombotic and obstetric complications, making accurate serological assessment essential for appropriate patient management.
- Standard APS testing is based on the established criteria antibodies—anticardiolipin (aCL), anti-β2 glycoprotein I (aβ2GPI), and lupus anticoagulant (LA)—which form the foundation of current classification criteria.
- Going beyond the criteria may broaden clinical coverage: considering non-criteria antiphospholipid antibodies in selected patients, particularly in obstetric settings, may provide additional serological insights when clinical suspicion persists despite negative or inconclusive standard testing.
Tests associated with this resource
Related instrument
Any assay, any sample, any time!
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.